CTI BIOPHARMA CORP - COM (CTIC)

CUSIP: 12648L106

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
67,913,349
Share change
-2,692,523
Total reported value
$27,428,348
Price per share
$0.41
Number of holders
46
Value change
-$1,059,247
Number of buys
15
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 12648L106?
CUSIP 12648L106 identifies CTIC - CTI BIOPHARMA CORP - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q4 2016

As of 31 Dec 2016, CTI BIOPHARMA CORP - COM (CTIC) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 67,913,349 shares. The largest 10 holders included BVF INC/IL, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., Stonepine Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, FMR LLC, BLAIR WILLIAM & CO/IL, and MILLENNIUM MANAGEMENT LLC. This page lists 46 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.